Azimuth Capital Investment Management’s Boston Scientific BSX Stock Holding History

Azimuth Capital Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,553	Closed	-$243K	–	300
2025 Q4	$243K	Hold	2,553	–	–	0.01%	283
2025 Q3	$249K	Hold	2,553	–	–	0.01%	274
2025 Q2	$274K	Sell	2,553 -372	-13%	-$37.6K	0.01%	275
2025 Q1	$295K	Sell	2,925 -300	-9%	-$30.2K	0.01%	270
2024 Q4	$288K	Sell	3,225 -100	-3%	-$8.8K	0.01%	277
2024 Q3	$279K	Sell	3,325 -248	-7%	-$19.6K	0.01%	281
2024 Q2	$275K	Sell	3,573 -300	-8%	-$22K	0.01%	279
2024 Q1	$265K	Sell	3,873 -196	-5%	-$12.6K	0.01%	279
2023 Q4	$235K	Buy	+4,069	New	+$217K	0.01%	285

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Azimuth Capital Investment Management's BSX Position: Q1 2026 in Review

Azimuth Capital Investment Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,553 shares — an estimated $243K sold.

Azimuth Capital Investment Management first reported a position in BSX in Q4 2023 and held it in 9 quarters. The position peaked at $295K in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Azimuth Capital Investment Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Azimuth Capital Investment Management sold 2,553 Boston Scientific shares in Q1 2026, an estimated $243K.
Azimuth Capital Investment Management first reported a position in Boston Scientific in Q4 2023 and held it in 9 quarters.
Azimuth Capital Investment Management's Boston Scientific position peaked at $295K in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.